ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.
Ginestier C, Adélaïde J, Gonçalvès A, Repellini L, Sircoulomb F, Letessier A, Finetti P, Geneix J, Charafe-Jauffret E, Bertucci F, Jacquemier J, Viens P, Birnbaum D.
Ginestier C, et al.
Oncogene. 2007 Nov 1;26(50):7163-9. doi: 10.1038/sj.onc.1210528. Epub 2007 May 21.
Oncogene. 2007.
PMID: 17525746